more info

Start date: 1 December 2020

End date: 31 December 2023

Number of projects: 3

Total budget: 26 910 137,48 €

EU contribution: 16 146 082,49 €

Website: n/a

Country:

European Commission Flag

Explore more: n/a

funds

ERDF: 16 146 082,49 €

„SYNTHAVERSE” SPÓŁKA AKCYJNA

PROGRAMMING PERIOD

1 - 3 of 3

PROJECT

TOTAL BUDGET

EU CONTRIBUTION

FUND

Implementation of the results of R & D work on innovative technology for the production of bladder cancer immunotherapy based on Moreau attenuated BCG tuberculosis

15 990 065,68 €

9 594 039,41 €

ERDF

BCG Biotechnology Innovation Centre

10 810 433,44 €

6 486 260,06 €

ERDF

Promotion Onko BCG – a drug used to treat superficial, epithelial, non-invasive bladder tumors in foreign markets

109 638,36 €

65 783,02 €

ERDF